Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Nautilus Biotechnology, Inc. - SIC # 3827 - OPTICAL INSTRUMENTS AND LENSES
Ticker
Exchange
SIC #
Website
Latest Ticker
NAUT
Nasdaq
3827
www.nautilus.bio
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Nautilus Biotechnology, Inc.
Nautilus Biotechnology Appoints Proteomics Commercial Leader Amber Faust as Vice President of Sales
- Mar 2nd, 2026 6:00 am
Nautilus Biotechnology, Inc. Q4 2025 Earnings Call Summary
- Feb 26th, 2026 6:07 pm
Nautilus Biotechnology Q4 Earnings Call Highlights
- Feb 26th, 2026 3:48 pm
Nautilus Biotechnology Inc (NAUT) Q4 2025 Earnings Call Highlights: Strategic Advances and ...
- Feb 26th, 2026 2:07 pm
Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2025 Financial Results
- Feb 26th, 2026 6:00 am
Nautilus Biotechnology Unveils Voyager Platform, Enabling Single-Molecule Iterative Mapping, at US HUPO 2026
- Feb 24th, 2026 6:00 am
Jefferies Upgrades BETA Technologies, Inc. (BETA) to Buy
- Feb 21st, 2026 7:41 pm
Nautilus Biotechnology to Participate in the TD Cowen 46th Annual Health Care Conference
- Feb 19th, 2026 2:05 pm
3 Penny Stocks With Market Caps Over $50M To Watch
- Feb 6th, 2026 5:05 am
Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
- Feb 5th, 2026 6:00 am
Nautilus Biotechnology and Weill Cornell Medicine-Qatar Collaborate with The Michael J. Fox Foundation to Advance Single-Molecule Proteomics Research in Parkinson’s Disease
- Jan 28th, 2026 6:00 am
Nautilus Biotechnology Launches Early Access Program for Novel Single-Molecule Proteomics Platform, Starting with Tau Proteoforms Assay
- Jan 8th, 2026 6:00 am
3 Penny Stocks With Market Caps Under $700M
- Jan 8th, 2026 5:05 am
Nautilus Biotechnology, Inc. (NASDAQ:NAUT) boasts of bullish insider sentiment with 33% ownership and they have been buying lately
- Dec 29th, 2025 5:00 am
Penny Stocks To Consider In December 2025
- Dec 1st, 2025 11:05 am
Nautilus Biotechnology Reports Successful Installation and Testing of its First Field Evaluation Unit at the Buck Institute for Research on Aging
- Nov 3rd, 2025 6:00 am
Nautilus (NAUT) Q3 2025 Earnings Call Transcript
- Oct 28th, 2025 3:55 pm
Nautilus Biotechnology And 2 Other Promising Penny Stocks
- Oct 28th, 2025 12:05 pm
Nautilus Biotechnology Reports Third Quarter 2025 Financial Results
- Oct 28th, 2025 6:00 am
We Think Nautilus Biotechnology (NASDAQ:NAUT) Can Afford To Drive Business Growth
- Oct 23rd, 2025 1:54 pm
Scroll